HDCRT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HDCRT, covering 2026-06-15 to 2026-06-15. Get the full timeline:
Most recent: Clinical Trial Results: HDCRT Plus Pembrolizumab in Advanced Malignancies [Phase 1]